重症COVID-19病程延长患者急性肾损伤的临床病理特征与结局:回顾性队列研究
该回顾性队列纳入81例ICU重症COVID-19患者,41例(50.6%)发生AKI,中位发生时间为病程21.0天。主要病因为感染性休克、容量不足和药物不良反应,主要病理为急性肾小管损伤,年龄和血清IL-6是AKI危险因素,KDIGO 3期AKI独立预测死亡。
要点
- 重症COVID-19病程延长者AKI发生率高,中位发生时间21天。
- 年龄和血清IL-6是AKI独立危险因素,KDIGO 3期AKI预测死亡。
- 肾组织病理以急性肾小管损伤为主,未检出病毒。
核心结论
- AKI是重症COVID-19病程晚期常见且多因素并发症,主要病理为急性肾小管损伤,高龄和高IL-6是危险因素,KDIGO 3期AKI独立预测死亡。
研究设计与样本
- 回顾性队列研究,纳入81例ICU重症COVID-19患者,分析AKI发生率、病因和结局,并对10例死亡AKI患者行肾组织病理检查。
主要发现
- 41例(50.6%)发生AKI,中位发生时间21.0天(IQR 9.5-26.0)。
- KDIGO 1、2、3期AKI比例分别为26.8%、31.7%、41.5%。
- AKI主要病因:感染性休克25/41(61.0%)、容量不足8/41(19.5%)、药物不良反应5/41(12.2%)。
- AKI危险因素:年龄每增加10岁(HR 1.83,95%CI 1.24-2.69,P=0.002)和血清IL-6水平(HR 1.83,95%CI 1.23-2.73,P=0.003)。
- KDIGO 3期AKI预测死亡,其他死亡危险因素包括男性、D-二聚体升高、血清IL-6水平和SOFA评分较高。
临床怎么用
- 对重症COVID-19病程较长患者应监测AKI,尤其高龄和高IL-6者。
- KDIGO 3期AKI提示死亡风险高,需加强监护。
局限性
- 回顾性单中心研究,样本量81例,病理仅10例,结论推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence, severity, and outcomes of AKI in COVID-19 varied in different reports. In patients critically ill with COVID-19, the clinicopathologic characteristics of AKI have not been described in detail. METHODS: This is a retrospective cohort study of 81 patients critically ill with COVID-19 in an intensive care unit. The incidence, etiologies, and outcomes of AKI were analyzed. Pathologic studies were performed in kidney tissues from ten deceased patients with AKI. RESULTS: A total of 41 (50.6%) patients experienced AKI in this study. The median time from illness to AKI was 21.0 (IQR, 9.5-26.0) days. The proportion of Kidney Disease Improving Global Outcomes (KDIGO) stage 1, stage 2, and stage 3 AKI were 26.8%, 31.7%, and 41.5%, respectively. The leading causes of AKI included septic shock (25 of 41, 61.0%), volume insufficiency (eight of 41, 19.5%), and adverse drug effects (five of 41, 12.2%). The risk factors for AKI included age (per 10 years) (HR, 1.83; 95% CI, 1.24 to 2.69; P=0.002) and serum IL-6 level (HR, 1.83; 95% CI, 1.23 to 2.73; P=0.003). KDIGO stage 3 AKI predicted death. Other potential risk factors for death included male sex, elevated D-dimer, serum IL-6 level, and higher Sequential Organ Failure Assessment score. The predominant pathologic finding was acute tubular injury. Nucleic acid tests and immunohistochemistry failed to detect the virus in kidney tissues. CONCLUSIONS: AKI was a common and multifactorial complication in patients critically ill with COVID-19 at the late stage of the disease course. The predominant pathologic finding was acute tubular injury. Older age and higher serum IL-6 level were risk factors of AKI, and KDIGO stage 3 AKI independently predicted death.
引用
- Xia P, Wen Y, Duan Y, et al. Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort. J Am Soc Nephrol. 2020. PMID: 32826326. doi:10.1681/ASN.2020040426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。